BioCentury | Jun 23, 2014
Emerging Company Profile

Amal: Party of two

Amal Therapeutics S.A. is developing a platform of recombinant cancer vaccines that may induce a more potent and durable response than earlier vaccines by activating two different cell types important in antitumor immunity and by...
BioCentury | Dec 6, 2012
Cover Story

A current affair in MS

...in Nature Medicine . The team included researchers from the University Medical Center Hamburg-Eppendorf , Geneva University Hospitals...
...Published online Dec. 6, 2012 Companies and Institutions Mentioned Catholic University Leuven , Leuven, Belgium Geneva University Hospitals...
BioCentury | Jun 13, 2011
Company News

Roche, Geneva University Hospitals, Swiss Institute of Bioinformatics, University of Geneva deal

...Roche partnered with the University of Geneva, Geneva University Hospitals and the Swiss Institute of Bioinformatics to develop...
...five-year deal, which may be extended. Details were not disclosed. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Geneva University Hospitals...
BioCentury | Jun 8, 2011
Company News

Merck, Roche in cancer diagnostics deal

...to cancer treatments. Details were not disclosed. Separately, Roche partnered with the University of Geneva, Geneva University Hospitals...
BioCentury | Jan 27, 2011
Tools & Techniques

Once a PON-1 an enzyme

...Fontana, head of the laboratory of haemostasis in the Department of Angiology and Haemostasis at Geneva University Hospitals...
...de la Recherche Scientifique , Paris, France Daiichi Sankyo Co. Ltd. (Tokyo:4568; Osaka:4568), Tokyo, Japan Geneva University Hospitals...
BioCentury | Sep 2, 2010
Distillery Therapeutics

Indication: Neurology

...Sorce, S. et al. J. Neurosci.; published online Aug. 25, 2010; doi:10.1523/JNEUROSCI.1491-10.2010 Contact: Karl-Heinz Krause, Geneva University Hospitals...
BioCentury | Sep 2, 2010
Targets & Mechanisms

Ketamine meets mTOR

...and Institutions Mentioned Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. Evotec AG (Xetra:EVT), Hamburg, Germany Geneva University Hospitals...
...S. et al. J. Neurosci .; published online Aug. 25, 2010; doi:10.1523/JNEUROSCI.1491-10.2010 Contact: Karl-Heinz Krause, Geneva University Hospitals...
...of researchers on the current study, led by Karl-Heinz Krause, professor of medicine at the Geneva University Hospitals...
BioCentury | Mar 25, 2010
Distillery Techniques

Technology: Assays & screens

...stem cell-like cells for the diagnosis of glioma tumors. Stemergie Biotechnology S.A., a spin-off from Geneva University Hospitals...
...diagnostics for cancer stem cells. SciBX 3(12); doi:10.1038/scibx.2010.387 Published online March 25, 2010 Patented by Geneva University Hospitals...
...Clément, V. et al. Nat. Methods; published online Feb. 21, 2010; doi:10.1038/nmeth.1430 Contact: Ivan Radovanovic, Geneva University Hospitals...
BioCentury | Mar 25, 2010
Distillery Therapeutics

Indication: Autoimmune disease

...Proc. Natl. Acad. Sci. USA; published online March 15, 2010; doi:10.1073/pnas.0912437107 Contact: Patrice H. Lalive, Geneva University Hospitals...
BioCentury | May 15, 2008
Tools & Techniques

Barking Up the Right Tree

...That study was conducted by researchers at the AIDS Research Alliance , Geneva University and Geneva University Hospitals...
...Research and Development Center , National Cancer Institute, Frederick, Md. Geneva University , Geneva, Switzerland Geneva University Hospitals...
Items per page:
1 - 10 of 10
BioCentury | Jun 23, 2014
Emerging Company Profile

Amal: Party of two

Amal Therapeutics S.A. is developing a platform of recombinant cancer vaccines that may induce a more potent and durable response than earlier vaccines by activating two different cell types important in antitumor immunity and by...
BioCentury | Dec 6, 2012
Cover Story

A current affair in MS

...in Nature Medicine . The team included researchers from the University Medical Center Hamburg-Eppendorf , Geneva University Hospitals...
...Published online Dec. 6, 2012 Companies and Institutions Mentioned Catholic University Leuven , Leuven, Belgium Geneva University Hospitals...
BioCentury | Jun 13, 2011
Company News

Roche, Geneva University Hospitals, Swiss Institute of Bioinformatics, University of Geneva deal

...Roche partnered with the University of Geneva, Geneva University Hospitals and the Swiss Institute of Bioinformatics to develop...
...five-year deal, which may be extended. Details were not disclosed. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Geneva University Hospitals...
BioCentury | Jun 8, 2011
Company News

Merck, Roche in cancer diagnostics deal

...to cancer treatments. Details were not disclosed. Separately, Roche partnered with the University of Geneva, Geneva University Hospitals...
BioCentury | Jan 27, 2011
Tools & Techniques

Once a PON-1 an enzyme

...Fontana, head of the laboratory of haemostasis in the Department of Angiology and Haemostasis at Geneva University Hospitals...
...de la Recherche Scientifique , Paris, France Daiichi Sankyo Co. Ltd. (Tokyo:4568; Osaka:4568), Tokyo, Japan Geneva University Hospitals...
BioCentury | Sep 2, 2010
Distillery Therapeutics

Indication: Neurology

...Sorce, S. et al. J. Neurosci.; published online Aug. 25, 2010; doi:10.1523/JNEUROSCI.1491-10.2010 Contact: Karl-Heinz Krause, Geneva University Hospitals...
BioCentury | Sep 2, 2010
Targets & Mechanisms

Ketamine meets mTOR

...and Institutions Mentioned Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. Evotec AG (Xetra:EVT), Hamburg, Germany Geneva University Hospitals...
...S. et al. J. Neurosci .; published online Aug. 25, 2010; doi:10.1523/JNEUROSCI.1491-10.2010 Contact: Karl-Heinz Krause, Geneva University Hospitals...
...of researchers on the current study, led by Karl-Heinz Krause, professor of medicine at the Geneva University Hospitals...
BioCentury | Mar 25, 2010
Distillery Techniques

Technology: Assays & screens

...stem cell-like cells for the diagnosis of glioma tumors. Stemergie Biotechnology S.A., a spin-off from Geneva University Hospitals...
...diagnostics for cancer stem cells. SciBX 3(12); doi:10.1038/scibx.2010.387 Published online March 25, 2010 Patented by Geneva University Hospitals...
...Clément, V. et al. Nat. Methods; published online Feb. 21, 2010; doi:10.1038/nmeth.1430 Contact: Ivan Radovanovic, Geneva University Hospitals...
BioCentury | Mar 25, 2010
Distillery Therapeutics

Indication: Autoimmune disease

...Proc. Natl. Acad. Sci. USA; published online March 15, 2010; doi:10.1073/pnas.0912437107 Contact: Patrice H. Lalive, Geneva University Hospitals...
BioCentury | May 15, 2008
Tools & Techniques

Barking Up the Right Tree

...That study was conducted by researchers at the AIDS Research Alliance , Geneva University and Geneva University Hospitals...
...Research and Development Center , National Cancer Institute, Frederick, Md. Geneva University , Geneva, Switzerland Geneva University Hospitals...
Items per page:
1 - 10 of 10